Literature DB >> 10696025

Effect of voxel position on single-voxel MR spectroscopy findings.

P E Ricci1, A Pitt, P J Keller, S W Coons, J E Heiserman.   

Abstract

BACKGROUND AND
PURPOSE: Single-voxel MR spectroscopy is a widely used tool for evaluating brain tumors. Although extensive data are available on the MR spectral appearance of tumors, less is known about the effect of voxel position on the accuracy of single-voxel MR spectroscopy findings. The purpose of this study was to test the hypothesis that the accuracy of single-voxel MR spectroscopy in the categorization of lesions as either tumor or not tumor is dependent on voxel position.
METHODS: Fifty single-voxel MR spectra acquired with a fully automated stimulated-echo spectroscopy sequence were reviewed retrospectively in 43 patients with new or previously treated intra-axial brain tumors. Spectra were analyzed for the presence of choline, creatine, N-acetylaspartate (NAA), and lipid/lactate. Choline/creatine and NAA/creatine peak area ratios were assessed qualitatively. Lesions were grouped into one of three categories on the basis of spectral pattern: tumor, not tumor, or indeterminate. Results of MR spectroscopy were compared with the final histopathologic diagnosis.
RESULTS: Histologic confirmation was obtained in 19 patients; MR spectra were interpretable in 17 of those. MR spectra correctly categorized nine of 17 lesions (six tumor, three nontumor). All eight misdiagnosed lesions were tumors. When the MR spectroscopy voxel included the enhancing edge of the lesion, the spectra correctly categorized seven of eight lesions (four of five tumors and all three cases of radiation necrosis). When the MR spectroscopy voxel was positioned centrally within the lesion, the spectra correctly reflected histologic outcome in two of nine lesions (all tumors).
CONCLUSION: The reliability of single-voxel MR spectroscopy findings is dependent on voxel position. Spectra obtained from voxels at the enhancing edge of a tumor more accurately reflect lesion histopathology than do spectra obtained from the lesion center, even if the centrally placed voxels contain solidly enhancing tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696025      PMCID: PMC7975341     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  52 in total

Review 1.  Clinical applications of proton MR spectroscopy.

Authors:  M Castillo; L Kwock; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  1996-01       Impact factor: 3.825

2.  Proton MR spectroscopy of experimental radiation-induced white matter injury.

Authors:  D M Yousem; R E Lenkinski; S Evans; D Allen; R O'Brien; W Curran; M Schnall; M Bennett; S L Wehrli; R I Grossman
Journal:  J Comput Assist Tomogr       Date:  1992 Jul-Aug       Impact factor: 1.826

3.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.

Authors:  P Demaerel; K Johannik; P Van Hecke; C Van Ongeval; S Verellen; G Marchal; G Wilms; C Plets; J Goffin; F Van Calenbergh
Journal:  J Comput Assist Tomogr       Date:  1991 Jan-Feb       Impact factor: 1.826

4.  Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour.

Authors:  J R van Dellen; A Danziger
Journal:  S Afr Med J       Date:  1978-02-04

5.  Clinical proton MR spectroscopy of neurodegenerative disease in childhood.

Authors:  A A Tzika; W S Ball; D B Vigneron; R S Dunn; D R Kirks
Journal:  AJNR Am J Neuroradiol       Date:  1993 Nov-Dec       Impact factor: 3.825

6.  1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue.

Authors:  A C Kuesel; G R Sutherland; W Halliday; I C Smith
Journal:  NMR Biomed       Date:  1994-05       Impact factor: 4.044

7.  Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions.

Authors:  S D Rand; R Prost; V Haughton; L Mark; J Strainer; J Johansen; T A Kim; V K Chetty; W Mueller; G Meyer; H Krouwer
Journal:  AJNR Am J Neuroradiol       Date:  1997-10       Impact factor: 3.825

Review 8.  Radiation injury of the brain.

Authors:  P E Valk; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  1991-01       Impact factor: 3.825

9.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.

Authors:  M J Fulham; A Bizzi; M J Dietz; H H Shih; R Raman; G S Sobering; J A Frank; A J Dwyer; J R Alger; G Di Chiro
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

10.  Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.

Authors:  P C Burger; E R Heinz; T Shibata; P Kleihues
Journal:  J Neurosurg       Date:  1988-05       Impact factor: 5.115

View more
  16 in total

1.  Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.

Authors:  I Chan Chiang; Yu-Ting Kuo; Chia-Ying Lu; Kwok-Wan Yeung; Wei-Chen Lin; Feng-O Sheu; Gin-Chung Liu
Journal:  Neuroradiology       Date:  2004-07-09       Impact factor: 2.804

2.  MR imaging characteristics of protoplasmic astrocytomas.

Authors:  Kevin L Tay; Alpha Tsui; Pramit M Phal; Katharine J Drummond; Brian M Tress
Journal:  Neuroradiology       Date:  2010-07-20       Impact factor: 2.804

Review 3.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.

Authors:  Emilie A Steffen-Smith; David J Venzon; Robyn S Bent; Sean J Hipp; Katherine E Warren
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-23       Impact factor: 7.038

5.  Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.

Authors:  Mikhail F Chernov; Motohiro Hayashi; Masahiro Izawa; Yuko Ono; Tomokatsu Hori
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

6.  In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors:  F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

Review 7.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

8.  Phase-encoded single-voxel magnetic resonance spectroscopy for suppressing outer volume signals at 7 Tesla.

Authors:  Ningzhi Li; Li An; Christopher Johnson; Jun Shen
Journal:  Biomed Spectrosc Imaging       Date:  2017-12-27

9.  Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease.

Authors:  Nan Wang; Hui Dong; Shichao Wei; Fuer Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

10.  MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy.

Authors:  Yun-Woo Chang; Hye-Kyung Yoon; Hyung-Jin Shin; Hong Gee Roh; Jae Min Cho
Journal:  Pediatr Radiol       Date:  2003-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.